C Béhar

1.0k total citations
34 papers, 421 citations indexed

About

C Béhar is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, C Béhar has authored 34 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 11 papers in Public Health, Environmental and Occupational Health and 8 papers in Genetics. Recurrent topics in C Béhar's work include Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). C Béhar is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). C Béhar collaborates with scholars based in France, Belgium and United States. C Béhar's co-authors include Jacques Otten, Françoise Mazingue, Yves Benoît, A Boilletot, Stefan Suciu, Alina Ferster, Françoise Méchinaud, A Robert, G. Solbu and E Plouvier and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PEDIATRICS.

In The Last Decade

C Béhar

30 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Béhar France 12 182 150 97 80 74 34 421
Federico Sackmann‐Muriel Argentina 13 144 0.8× 152 1.0× 68 0.7× 82 1.0× 75 1.0× 25 396
Vico Vecchi Italy 12 127 0.7× 166 1.1× 105 1.1× 80 1.0× 63 0.9× 28 417
B. Stollmann Germany 11 224 1.2× 245 1.6× 53 0.5× 101 1.3× 62 0.8× 22 436
Susan R. Wiersma United States 13 260 1.4× 175 1.2× 103 1.1× 48 0.6× 75 1.0× 16 517
Federico Sackmann Muriel Argentina 12 102 0.6× 156 1.0× 72 0.7× 65 0.8× 98 1.3× 21 438
CM Niemeyer United States 9 346 1.9× 248 1.7× 58 0.6× 122 1.5× 136 1.8× 15 631
PG Dyment United States 6 90 0.5× 196 1.3× 50 0.5× 127 1.6× 70 0.9× 11 330
Naoto Fujita Japan 12 106 0.6× 104 0.7× 74 0.8× 50 0.6× 56 0.8× 42 392
A Boilletot France 9 76 0.4× 87 0.6× 52 0.5× 70 0.9× 21 0.3× 26 297
E Bureo Spain 10 342 1.9× 216 1.4× 31 0.3× 69 0.9× 89 1.2× 16 434

Countries citing papers authored by C Béhar

Since Specialization
Citations

This map shows the geographic impact of C Béhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Béhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Béhar more than expected).

Fields of papers citing papers by C Béhar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Béhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Béhar. The network helps show where C Béhar may publish in the future.

Co-authorship network of co-authors of C Béhar

This figure shows the co-authorship network connecting the top 25 collaborators of C Béhar. A scholar is included among the top collaborators of C Béhar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Béhar. C Béhar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrand, Christophe, Francine Garnache‐Ottou, Fabrice Larosa, et al.. (2011). Systematic donor blood qualification by flow cytometry would have been able to avoid CLL‐type MBL transmission after unrelated hematopoietic stem cell transplantation. European Journal Of Haematology. 88(3). 269–272. 6 indexed citations
2.
Lefèbvre, François, Martine Münzer, C Béhar, et al.. (2008). SFCP-002 – Chirurgie viscérale – Neurofibromatose de type 1 : 3 nouveaux cas de dégénérescence sarcomateuse. Archives de Pédiatrie. 15(5). 887–887.
3.
Giansily‐Blaizot, Muriel, Philippe Khau Van Kien, C Béhar, et al.. (2007). Characterisation of a large complex intragenic re‐arrangement in the FVII gene (F7) avoiding misdiagnosis in inherited factor VII deficiency. British Journal of Haematology. 138(3). 359–365. 8 indexed citations
4.
5.
Blouin, Pascale, Anne Auvrignon, Anne Pagnier, et al.. (2005). Syndrome d'Evans : étude rétrospective de la société d'hématologie et d'immunologie pédiatrique (36 cas). Archives de Pédiatrie. 12(11). 1600–1607. 16 indexed citations
6.
Millot, Frédéric, Joëlle Guilhot, Brigitte Nelken, et al.. (2004). Results of a Phase II Trial Testing Interferon Alpha 2b and Cytarabine in Children with Chronic Myelogenous Leukemia.. Blood. 104(11). 1000–1000. 2 indexed citations
7.
Otten, Jacques, N Philippe, Stefan Suciu, et al.. (2002). The Children Leukemia Group. European Journal of Cancer. 38. 44–49. 9 indexed citations
8.
Coze, Carole, Olivier Hartmann, Jean Michon, et al.. (1997). NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology.. Journal of Clinical Oncology. 15(12). 3433–3440. 51 indexed citations
9.
Lutz, P, G Souillet, Y Bertrand, et al.. (1996). Juvenile myelomonocytic leukemia: analyses of treatment results in the EORTC Children's Leukemia Cooperative Group (CLCG).. PubMed. 18(6). 1111–6. 31 indexed citations
10.
Béhar, C, Stefan Suciu, Yves Benoît, et al.. (1996). Mitoxantrone-containing regimen for treatment of childhood acute leukemia AML and analysis of prognostic factors: Results of the EORTC Children Leukemia Cooperative Study 58872. Medical and Pediatric Oncology. 26(3). 173–179. 19 indexed citations
11.
Ferster, Alina, Yves Bertrand, Yves Benoît, et al.. (1994). Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC‐Childhood Leukaemia Cooperative Group. British Journal of Haematology. 86(2). 284–290. 53 indexed citations
12.
Couanet, D., et al.. (1994). What Is the prognostic value of osteomedullary uptake on MIBG scan in neuroblastoma patients under one year of age?. Medical and Pediatric Oncology. 22(2). 107–114. 17 indexed citations
13.
Babin-Boilletot, A, F Flamant, Marie‐José Terrier‐Lacombe, et al.. (1993). Primitive malignant nonepithelial hepatic tumors in children. Medical and Pediatric Oncology. 21(9). 634–639. 15 indexed citations
14.
Milano, G., A. Thyss, Geneviève Laureys, et al.. (1990). CSF drug levels for children with acute lymphoblastic leukemia treated by 5 g/m2 methotrexate. European Journal of Cancer and Clinical Oncology. 26(4). 492–495. 25 indexed citations
15.
Boilletot, A, C Béhar, Yves Benoît, et al.. (1987). Treatment of Acute Lymphoblastic Leukemia in Children with the BFM Protocol A Cooperative Pilot Study. Journal of Pediatric Hematology/Oncology. 9(4). 317–323. 5 indexed citations
16.
Plouvier, Emmanuel, P Hervé, M. Flesch, et al.. (1985). [Autograft of bone marrow following intensive treatment in acute lymphoid leukemia in children].. PubMed. 42(6). 429–35. 1 indexed citations
17.
Gaillard, Dominique, C Béhar, Philippe Birembaut, et al.. (1982). Néphroblastome kystique partiellement différencié.. 39(7).
18.
Hervé, P, Emmanuel Plouvier, Bernard Lamy, et al.. (1981). [Autologous haematopoietic stem cell transplantation. Preliminary results of a regional multicentric study (author's transl)].. PubMed. 10(24). 2001–6. 3 indexed citations
19.
Béhar, C, et al.. (1979). Lymphoblastic leukaemia and Kaposi's sarcoma. Pediatric Radiology. 8(3). 185–187. 8 indexed citations
20.
Béhar, C, et al.. (1976). Maladie de Hodgkin chez l'enfant. stade IV. Traitement et résultats. 33(6). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Federico Sackmann‐Muriel Breakdown of academic impact, for papers by Vico Vecchi Breakdown of academic impact, for papers by B. Stollmann Breakdown of academic impact, for papers by Susan R. Wiersma Breakdown of academic impact, for papers by Federico Sackmann Muriel Breakdown of academic impact, for papers by CM Niemeyer Breakdown of academic impact, for papers by PG Dyment Breakdown of academic impact, for papers by Naoto Fujita Breakdown of academic impact, for papers by A Boilletot Breakdown of academic impact, for papers by E Bureo
Rankless by CCL
2026